Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Alkermes (ALKS) EBITDA (2016 - 2025)

Historic EBITDA for Alkermes (ALKS) over the last 16 years, with Q3 2025 value amounting to $83.1 million.

  • Alkermes' EBITDA fell 1379.1% to $83.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $337.3 million, marking a year-over-year decrease of 73.65%. This contributed to the annual value of $368.2 million for FY2024, which is 128.65% up from last year.
  • Latest data reveals that Alkermes reported EBITDA of $83.1 million as of Q3 2025, which was down 1379.1% from $87.2 million recorded in Q2 2025.
  • Alkermes' EBITDA's 5-year high stood at $237.8 million during Q2 2023, with a 5-year trough of -$66.3 million in Q3 2022.
  • Moreover, its 5-year median value for EBITDA was $23.0 million (2025), whereas its average is $37.3 million.
  • As far as peak fluctuations go, Alkermes' EBITDA tumbled by 684089.71% in 2022, and later surged by 83404.45% in 2023.
  • Quarter analysis of 5 years shows Alkermes' EBITDA stood at -$379000.0 in 2021, then crashed by 6840.9% to -$26.3 million in 2022, then soared by 539.99% to $115.7 million in 2023, then grew by 24.51% to $144.1 million in 2024, then plummeted by 42.33% to $83.1 million in 2025.
  • Its last three reported values are $83.1 million in Q3 2025, $87.2 million for Q2 2025, and $23.0 million during Q1 2025.